GLP-1 Receptor Agonists Show Early Promise for Reducing Cravings in Alcohol and Opioid Use Disorders
Clinical trials and real-world reports in 2025 and 2026 indicate that GLP-1 medications such as semaglutide may help lower heavy drinking days and cravings among people with alcohol use disorder, with emerging signals for other substances, though these drugs remain unapproved by the FDA for addiction treatment.
Admin · Nov 11, 2026 · 4 min read